Multimedia
From the Journals
More evidence hydroxychloroquine is ineffective, harmful in COVID-19
New observational data show that hydroxychloroquine it is not only without benefit for COVID-19 but also increases death and arrhythmias.
For Residents
Double Masking and Decontamination: A Doctor's COVID-19 Routine
Gary S. Ferenchick, MD, MS, a professor of medicine at Michigan State University, interviewed his daughter, Hannah R.B. Ferenchick, MD, an...
Video
Expert outlines strategies for managing migraine in women
Dr. Susan Hutchinson discusses how to make informed treatment choices based on the life stage of the woman with migraine.
Video
Small-molecule CGRP receptor antagonists may pose a risk during stroke
The drugs could impair brain blood vessels during ischemic events.
For Residents
'Silent Hypoxemia' and Other Curious Clinical Observations in COVID-19
Gary S. Ferenchick, MD, MS, a professor of medicine at Michigan State University, interviewed his daughter, Hannah R.B. Ferenchick, MD, an...
Latest News
How texting unites Seattle’s critical care departments
A basic smartphone feature becomes a crucial tool to keep the region’s ICUs connected.
Latest News
Actor Alan Alda discusses using empathy as an antidote to burnout
The practice “kind of opens people up to one another, which inspirits them,” the iconic actor said.
Feature
Disputes over malpractice blame: Do allocations matter?
A legal battle between a doctor and insurer highlight conflicts that can arise when settling medical malpractice claims.
Video
Quarterly intravenous eptinezumab prevents migraine
PHILADELPHIA – Results from a pair of dose-ranging, randomized studies showed one IV eptinezumab dose cut migraine recurrences for 3 months.
Conference Coverage
Nearly 20% of migraineurs use opioids for migraine
PHILADELPHIA – People with 4 or more migraine headache days per month are more likely to use opioids, compared with people with fewer migraine...